Delhi High Court restrains Cipla from infringing Novartis’ respiratory drug

Upholding Justice Manmohan Singh’s order of January 2015, the division bench of Badar Durrez Ahmed and Sanjeev Sachdeva, JJ. of the Delhi High Court today restrained Cipla from infringing Novartis’ patent on its drug Indacaterol – marketed under the name “Onbrez”.

Onbrez is a respiratory drug, which provides relief to persons suffering